Research Project
Grant-in-Aid for Challenging Exploratory Research
Next generation sequencing based targeted panel analysis was performed on 28 patients with megalencephaly. We detected a pathogenic mutation in 13 of 27 patients (48.1%) including one patient with a mosaic mutation which was only detected in the affected brain tissue. Western blot analysis using lymphoblastoid cell lines established from peripheral leukocytes with phospho-S6 antibody was performed in 7 mutation-positive patients, and significantly increased phospho-S6 representing abnormal activation of mTOR pathway was found in all 7 patients. Increased phospho-S6 was also detected in 1 of 8 mutation-negative patients. Collectively, our combination of genetic and biochemical analyses is useful for diagnosis of genetic megalencephaly syndromes.
All 2018 2017 2016
All Journal Article (3 results) (of which Int'l Joint Research: 1 results, Peer Reviewed: 3 results, Open Access: 2 results) Presentation (2 results) (of which Int'l Joint Research: 1 results)
Scientific Reports
Volume: 8 Issue: 1 Pages: 5608-5608
10.1038/s41598-018-23978-z
BMC Med Genet.
Volume: 18 Issue: 1 Pages: 4-4
10.1186/s12881-016-0363-6
Journal of Human Genetics
Volume: 62 Issue: 9 Pages: 861-863
10.1038/jhg.2017.53